National and Kapodistrian University of Athens
Neuropsychiatric lupus: pathogenetic and clinical aspects
Abstract
dc:descriptionNeuropsychiatric systemic lupus erythematosus (NPSLE) is an emerging frontier inlupus care encompassing a wide spectrum of clinical manifestations. Despite recentprogress in the field, understanding of NPSLE in terms of diagnosis, pathogenesis andtreatment remains deficient, because of limited access to tissue, diversity andcomplexity of clinical manifestations, and overlap with non-SLE relatedneuropsychiatric events.As part of my thesis, we established the Attikon SLE cohort, one of the largest in theworld with close to 800 patients, and utilized it to study NPSLE. In this cohort,neuropsychiatric disease as presenting manifestation was present in 11.5% of patients,while 17.6% of patients exhibited at least one lupus-related neuropsychiatric event untilmost recent follow-up. Of note, neuropsychiatric involvement at onset, wasindependently associated with transition from mild/moderate to more severe disease.Demyelinating events were observed in 3.7% of SLE patients, equally distributedbetween primary SLE-demyelination and overlap SLE-MS. We also identified asignificant number of patients with demyelination who did not fulfill criteria for eitherMS or SLE and these patients exhibit lupus-like autoimmune features and mayrepresent a distinct entity, which we coined ‘demyelination with autoimmune features’.In reference to NPSLE pathogenesis, I used the NZB/W-F1 mouse model, whichdevelops spontaneous nephritis at 6 months of age, to study neuropsychiatric disease.In this strain, at the pre-nephritic stage (age 3 months), although the blood brain barrier(BBB) remains intact, we found hippocampus-related behavioral deficits resemblinghuman diffuse neuropsychiatric disease, including depression, anxiety, decreasedcognition and impaired coordination. This phenotype is mediated by disruptedhippocampal neurogenesis, with hippocampal neural stem cells (hiNSCs) exhibitingincreased proliferation combined with decreased differentiation and survival due toexcessive apoptosis. This is accompanied by activation of the microglia towards aninflammatory-state with increased secretion of pro-inflammatory cytokines andchemokines. Later in the course of the disease, when mice develop nephritis (6 months)a disrupted BBB allows immune components of peripheral blood, particularly B-cells,to penetrate into the hippocampus, further enhancing inflammation with locally increased levels of IL-6, IL-12, IL-18 and IL-23. Among these cytokines, IL-6 and IL18 directly induce apoptosis of adult hiNSCs ex vivo, while for the remaining cytokinesthere are no receptors to exert effects on adult hiNSCs. Of note, in contrast to the prenephritic stage, an interferon (IFN)-α signature was present in this stage. We conclude that an intact BBB with microglial activation disrupting the formation of new neuronswithin the hippocampus represent early neuropsychiatric changes in NPSLE. In theNZB/W-F1 model, neuropsychiatric disease is an early event that occurs prior togeneralized lupus immunologic activity. Early intervention targeting activation ofmicroglia/inhibition of IL-6 or IL-18, or protection of neurons may be a reasonabletherapeutic strategy, while in later stages IFN targeting may be more effective.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Nikolopoulos, Dionysios
- Νικολόπουλος, Διονύσιος
Subjects
dc:subject × 14Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/52754